Replies to post #90807 on Cytodyn Inc (CYDY)

[All-Bidness]

Whether they know or not is not the concern. Whether they allow us to proceed is. Remdesivir trial primary end point was moved, and they they allowed EUA. Clearly it doesn't work, it doesn't reduce viral load. Giliad spent $2m in Q1 on lobbying. It costs $$$ to make things happen, we have 10+ years of a clean safety record with HIV patients AND, we reduce viral load. Why not give us EUA already???